Clinical Trials Logo

Clinical Trial Summary

There has been increasing evidence for different rates of natural aging in humans and one of the best organs to study human aging is skin. Studies have demonstrated anti-aging effects of topical agents (such as creams, gels, lotions, or ointments) and one of them, retinol or vitamin A, was shown to decrease fine wrinkling in skin of older individuals. Additionally, studies of retinol in humans have largely occurred in white populations and so this study aims to focus on skin aging in individuals of East Asian descent as they represent a majority of the world population. This study aims to better characterize the molecular basis of rejuvenation effects and to potentially discover new topical agents with similar and/or more effective preservation of skin youthfulness.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02906566
Study type Interventional
Source Stanford University
Contact
Status Completed
Phase Phase 4
Start date November 2015
Completion date March 9, 2018

See also
  Status Clinical Trial Phase
Completed NCT01466413 - Two Formulations of ELAPR Compared to Restylane® Vital Light Following Repeat Implants in the Upper Arm Dermis Phase 1
Completed NCT01212809 - Comparative Study of Reconstituted JUVÉDERM® Ultra vs COSMODERM® 1 for Lip and Cheek Lines, Folds or Wrinkles Phase 4
Completed NCT01529788 - Onabotulinum Toxin Type A and Abobotulinum Toxin Type A Crow's Feet Rhytid Study Phase 4
Completed NCT02391935 - Study of Intradermal Injections of RCS-01 in Male and Female Subjects Phase 1